Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

Authors: Maron, M. S.¹, Masri, A.², Nassif, M. E.², Barriales-Villa, R.², Arad, M.³, Cardim, N.³, Choudhury, L.³, Claggett, B.³, Coats, CJ³, DOngen, H.-D., Garcia-Pavia, P., Hagtge, A. A., Januzzi, J. L., Lee, M. M. Y., Lewis, G. D., Ma, C.-S., Michels, M., Olivotto, Oreziak, A., Owens, A. T.

Source: New England Journal of Medicine; 5/30/2024, Vol. 390 Issue 20, p1849-1861, 13p